Ocularis Pharma's Other Investors

Ocularis Pharma raised a round of funding on , . Investors include Capital Midwest Fund.

Night Vision Complaints, which range from patient dissatisfaction to complete impairment due to glare, halos, starbursts, ghosting patterns, poor contrast and poor depth perception in dim light, have …

Articles about Ocularis Pharma's Other Investors: